Respiratory symptoms as predictor of impairment in COPD: the Guangzhou Biobank cohort study Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008
Prevalence and demographics of asthma - COPD overlap (ACO) among asthma and COPD patients in the pulmonary clinic of the University of the Philippines - Philippine General Hospital Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019
Prevalence of respiratory symptoms in two general practice populations in Manchester UK Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015
The prevalence of asthma–chronic obstructive pulmonary disease overlap syndrome (ACOS) in a Northern Italy general population sample Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015
Prevalence of respiratory symptoms in subjects with and without COPD in 5 Latin American cities: the PLATINO study Source: Annual Congress 2007 - Environmental and clinical aspects of COPD Year: 2007
Evaluation of respiratory symptoms in COPD patients from seven Latin America countries: The LASSYC Study Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017
Population surveillance in North West Adelaide: physical activity associated with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 383s Year: 2005
Asthma and COPD overlap syndrome (ACOS) is related to a high burden of sleep disturbance and respiratory symptoms: results from the RHINE and Swedish GA2LEN surveys. Source: International Congress 2017 – Asthma and ACOS: predictors and clinical characteristics Year: 2017
Effect of non-response on prevalence of respiratory symptoms in the West Sweden Asthma Study. Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases Year: 2020
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey Source: Eur Respir J 2002; 20: 799-805 Year: 2002
Respiratory medication use, lung function, and prior diagnosis of obstructive lung disease in five Latin American cities: the PLATINO study Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD Year: 2008
Patterns in patient experience of COPD exacerbations in the UK, Denmark and Netherlands - a qualitative study Source: Eur Respir J 2003; 22: Suppl. 45, 67s Year: 2003
Respiratory symptoms, bronchitis and asthma in children of Central and Eastern Europe Source: Eur Respir J 2002; 20: 890-898 Year: 2002
Prevalence of asthma, asthma-like and chronic respiratory symptoms in 30 villages around Beijing, China Source: Eur Respir J 2001; 18: Suppl. 33, 109s Year: 2001
High prevalence of respiratory symptoms and airflow limitation on World COPD Day in Zwolle, The Netherlands Source: Eur Respir J 2006; 28: Suppl. 50, 280s Year: 2006
Impact of bronchiectasis on severe asthma: data from the “Severe Asthma Network Italy” (SANI) registry Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018
Population surveillance in North West Adelaide: the impact of diagnosed and undiagnosed chronic obstructive pulmonary disease (COPD) on quality of life Source: Eur Respir J 2005; 26: Suppl. 49, 383s Year: 2005
Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013
Applicability of the global lung initiative (GLI) spirometric reference values for northern Sweden Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014
Treatment of COPD Exacerbation in Switzerland - results and recommendations of the European COPD Audit Source: International Congress 2017 – COPD management Year: 2017